Correlation Between IES Holdings and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IES Holdings and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IES Holdings and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IES Holdings and Silo Pharma, you can compare the effects of market volatilities on IES Holdings and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IES Holdings with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of IES Holdings and Silo Pharma.

Diversification Opportunities for IES Holdings and Silo Pharma

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between IES and Silo is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding IES Holdings and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and IES Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IES Holdings are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of IES Holdings i.e., IES Holdings and Silo Pharma go up and down completely randomly.

Pair Corralation between IES Holdings and Silo Pharma

Given the investment horizon of 90 days IES Holdings is expected to generate 0.35 times more return on investment than Silo Pharma. However, IES Holdings is 2.85 times less risky than Silo Pharma. It trades about 0.16 of its potential returns per unit of risk. Silo Pharma is currently generating about 0.03 per unit of risk. If you would invest  8,300  in IES Holdings on September 4, 2024 and sell it today you would earn a total of  21,280  from holding IES Holdings or generate 256.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

IES Holdings  vs.  Silo Pharma

 Performance 
       Timeline  
IES Holdings 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in IES Holdings are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, IES Holdings exhibited solid returns over the last few months and may actually be approaching a breakup point.
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

IES Holdings and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IES Holdings and Silo Pharma

The main advantage of trading using opposite IES Holdings and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IES Holdings position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind IES Holdings and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum